Login / Signup

Efficacy and safety of once daily oral administration of sodium-glucose cotransporter-2 inhibitor velagliflozin compared with twice daily insulin injection in diabetic cats.

Stijn J M NiessenHans S KooistraYaiza ForcadaCharlotte Reinhard BjørnvadBalazs AlbrechtFranziska RoessnerEsther HerberichCarla Kroh
Published in: Journal of veterinary internal medicine (2024)
Once daily oral administration of velagliflozin was noninferior to insulin injections, showed good QoL and glycemia without clinical hypoglycemia.
Keyphrases
  • type diabetes
  • glycemic control
  • physical activity
  • ultrasound guided
  • insulin resistance
  • metabolic syndrome
  • platelet rich plasma